New Rat Bladder Cancer Model for Treatment Testing
Author Information
Author(s): Xiao Z, McCallum T J, Brown K M, Miller G G, Halls S B, Parney I, Moore R B
Primary Institution: University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada
Hypothesis
The study aimed to develop and characterize a novel transplantable orthotopic rat bladder transitional cell tumor model for preclinical evaluation of new treatments.
Conclusion
The orthotopic AY-27 TCC model is highly reproducible and suitable for preclinical studies on experimental intravesical therapies.
Supporting Evidence
- The overall tumor establishment was 95% in the study.
- 80 out of 82 animals developed transitional cell carcinoma at 16 days.
- Histological examination confirmed the presence of grade II–III TCC.
Takeaway
Researchers created a new model of bladder cancer in rats to help test new treatments, and it worked really well.
Methodology
AY-27 rat bladder transitional cell carcinoma cells were transplanted into Fischer CDF344 female rats, and tumor growth was monitored using MRI and histological examinations.
Participant Demographics
Fischer CDF344 female rats were used in the study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website